Food reduces oral semaglutide bioavailability by approximately 60%, making adherence to fasting requirements essential for therapeutic effectiveness
A product may be mislabelled, contaminated, too concentrated, too weak, or handled outside appropriate storage conditions
GLP-1 receptor agonists mimic the GLP-1 hormone that is naturally released in the gastrointestinal tract in response to eating
The majority of clinical trials followed people taking semaglutide for one to two years
Appetite Regulation Without Significant Weight Loss Microdosing GLP-1 medications can help regulate appetite and prevent overeating, even for individuals who do not need or want to lose a large amount of weight
Rather than trying to change everything at once, focus on building a few sustainable habits that you can maintain over the long term